Skip to content
Research Article Open access CC BY 3.0

Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy – The Turning Point of Cell-Based Regenerative Medicine

Xuejun H. Parsons

Biotechnology Journal International · pp. 424–457 · Published 13 Jul 2013

10.9734/BBJ/2013/4309

Abstract

To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for regenerating the damaged or lost CNS structure and circuitry in a wide range of neurological disorders. Similarly, the lack of a clinically-suitable human cardiomyocyte source with adequate myocardium regenerative potential has been the major setback in regenerating the damaged human heart. Given the limited capacity of the CNS and heart for self-repair, there is a large unmet healthcare need to develop stem cell therapies to provide optimal regeneration and reconstruction treatment options to restore normal tissues and function. Derivation of human embryonic stem cells (hESCs) provides a powerful in vitro model system to investigate molecular controls in human embryogenesis as well as an unlimited source to generate the diversity of human somatic cell types for regenerative medicine. However, realizing the developmental and therapeutic potential of hESC derivatives has been hindered by the inefficiency and instability of generating clinically-relevant functional cells from pluripotent cells through conventional uncontrollable and incomplete multi-lineage differentiation. Recent advances and breakthroughs in hESC research have overcome some major obstacles in bringing hESC therapy derivatives towards clinical applications, including establishing defined culture systems for de novo derivation and maintenance of clinical-grade pluripotent hESCs and lineage-specific differentiation of pluripotent hESCs by small molecule induction. Retinoic acid was identified as sufficient to induce the specification of neuroectoderm direct from the pluripotent state of hESCs and trigger a cascade of neuronal lineage-specific progression to human neuronal progenitors and neurons of the developing CNS in high efficiency, purity, and neuronal lineage specificity by promoting nuclear translocation of the neuronal specific transcription factor Nurr-1. Similarly, nicotinamide was rendered sufficient to induce the specification of cardiomesoderm direct from the pluripotent state of hESCs by promoting the expression of the earliest cardiac-specific transcription factor Csx/Nkx2.5 and triggering progression to cardiac precursors and beating cardiomyocytes with high efficiency. This technology breakthrough enables direct conversion of pluripotent hESCs into a large supply of high purity neuronal cells or heart muscle cells with adequate capacity to regenerate CNS neurons and contractile heart muscles for developing safe and effective stem cell therapies. Transforming pluripotent hESCs into fate-restricted therapy derivatives dramatically increases the clinical efficacy of graft-dependent repair and safety of hESC-derived cellular products. Such milestone advances and medical innovations in hESC research allow generation of a large supply of clinical-grade hESC therapy derivatives targeting for major health problems, bringing cell-based regenerative medicine to a turning point

Human embryonic stem cell stem cell pluripotent tissue engineering cell therapy regenerative medicine neurological disease heart disease

References (125)

  1. 1 Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering [DOI]
  2. 2 Genome-wide maps of chromatin state in pluripotent and lineage-committed cells [DOI]
  3. 3 Reprogramming of human somatic cells to pluripotency with defined factors [DOI]
  4. 4 Hydrogels as extracellular matrix mimics for 3D cell culture [DOI]
  5. 5 In vitro differentiation of transplantable neural precursors from human embryonic stem cells [DOI]
  6. 6 Feeder-free growth of undifferentiated human embryonic stem cells [DOI]
  7. 7 Efficient differentiation of human embryonic stem cells to definitive endoderm [DOI]
  8. 8 Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering [DOI]
  9. 9 Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population [DOI]
  10. 10 Derivation of human embryonic stem cells in defined conditions [DOI]
  11. 11 Derivation of Embryonic Stem-Cell Lines from Human Blastocysts [DOI]
  12. 12 Cell replacement therapies for central nervous system disorders [DOI]
  13. 13 Electromechanical integration of cardiomyocytes derived from human embryonic stem cells [DOI]
  14. 14 Engraftable human neural stem cells respond to development cues, replace neurons, and express foreign genes [DOI]
  15. 15 Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells [DOI]
  16. 16 Direct reprogramming of human neural stem cells by OCT4 [DOI]
  17. 17 Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage [DOI]
  18. 18 SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells [DOI]
  19. 19 Developmental Origin of a Bipotential Myocardial and Smooth Muscle Cell Precursor in the Mammalian Heart [DOI]
  20. 20 Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells [DOI]
  21. 21 An Nkx2-5/Bmp2/Smad1 Negative Feedback Loop Controls Heart Progenitor Specification and Proliferation [DOI]
  22. 22 Enrichment of Neurons and Neural Precursors from Human Embryonic Stem Cells [DOI]
  23. 23 Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions [DOI]
  24. 24 Induced neuronal differentiation of human embryonic stem cells [DOI]
  25. 25 Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian Rats [DOI]
  26. 26 Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells [DOI]
  27. 27 Derivation of engraftable skeletal myoblasts from human embryonic stem cells [DOI]
  28. 28 Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats [DOI]
  29. 29 Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats [DOI]
  30. 30 Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells [DOI]
  31. 31 A Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions [DOI]
  32. 32 Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension [DOI]
  33. 33 Directed differentiation of human pluripotent cells to neural crest stem cells [DOI]
  34. 34 Adherent Self-Renewable Human Embryonic Stem Cell-Derived Neural Stem Cell Line: Functional Engraftment in Experimental Stroke Model [DOI]
  35. 35 Cellular and molecular control of neurogenesis in the mammalian telencephalon [DOI]
  36. 36 The Natural and Engineered 3D Microenvironment as a Regulatory Cue During Stem Cell Fate Determination [DOI]
  37. 37 A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation [DOI]
  38. 38 Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes [DOI]
  39. 39 Methods for the Derivation and Use of Cardiomyocytes from Human Pluripotent Stem Cells [DOI]
  40. 40 Molecular Embryogenesis of the Heart [DOI]
  41. 41 Human embryonic stem cells and cardiac repair [DOI]
  42. 42 Derivation of High Purity Neuronal Progenitors from Human Embryonic Stem Cells [DOI]
  43. 43 Efficient Derivation of Human Neuronal Progenitors and Neurons from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction [DOI]
  44. 44 Defining Conditions for Sustaining Epiblast Pluripotence Enables Direct Induction of Clinically-Suitable Human Myocardial Grafts from Biologics-Free Human Embryonic Stem Cells [DOI]
  45. 45 An Engraftable Human Embryonic Stem Cell Neuronal Lineage-Specific Derivative Retains Embryonic Chromatin Plasticity for Scale-Up CNS Regeneration [DOI]
  46. 46 The Dynamics of Global Chromatin Remodeling are Pivotal for Tracking the Normal Pluripotency of Human Embryonic Stem Cells Xuejun H. Parsons [DOI]
  47. 47 Generation of Tyrosine Hydroxylase-Producing Neurons from Precursors of the Embryonic and Adult Forebrain [DOI]
  48. 48 Differentiation of dopaminergic neurons from human embryonic stem cells: Modulation of differentiation by FGF-20 [DOI]
  49. 49 Genome-Wide Epigenetic Analysis of Human Pluripotent Stem Cells by ChIP and ChIP-Seq [DOI]
  50. 50 Embedding the Future of Regenerative Medicine into the Open Epigenomic Landscape of Pluripotent Human Embryonic Stem Cells.
  51. 51 Embryonic Stem Cell Lines Derived from Human Blastocysts [DOI]
  52. 52 Epigenetic memory in induced pluripotent stem cells [DOI]
  53. 53 New cell lines from mouse epiblast share defining features with human embryonic stem cells [DOI]
  54. 54 Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells [DOI]
  55. 55 Direct isolation of human central nervous system stem cells [DOI]
  56. 56 Immunogenicity of induced pluripotent stem cells [DOI]
  57. 57 Somatic coding mutations in human induced pluripotent stem cells [DOI]
  58. 58 Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease [DOI]
  59. 59 Multipotent Embryonic Isl1+ Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification [DOI]
  60. 60 Derivation of midbrain dopamine neurons from human embryonic stem cells [DOI]
  61. 61 Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells [DOI]
  62. 62 Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells [DOI]
  63. 63 Human embryonic stem cells express an immunogenic nonhuman sialic acid [DOI]
  64. 64 Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds [DOI]
  65. 65 Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells [DOI]
  66. 66 Early Lineage Segregation between Epiblast and Primitive Endoderm in Mouse Blastocysts through the Grb2-MAPK Pathway [DOI]
  67. 67 Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs [DOI]
  68. 68 The therapeutic potential of neural stem cells [DOI]
  69. 69 Multipotent Flk-1+ Cardiovascular Progenitor Cells Give Rise to the Cardiomyocyte, Endothelial, and Vascular Smooth Muscle Lineages [DOI]
  70. 70 Making or Breaking the Heart: From Lineage Determination to Morphogenesis [DOI]
  71. 71 Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy [DOI]
  72. 72 Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage [DOI]
  73. 73 Transplantation of Human Embryonic Stem Cell-Derived Cardiomyocytes Improves Myocardial Performance in Infarcted Rat Hearts [DOI]
  74. 74 Direct reprogramming of mouse fibroblasts to neural progenitors [DOI]
  75. 75 Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511 [DOI]
  76. 76 Stem-cell-based therapy and lessons from the heart [DOI]
  77. 77 Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons [DOI]
  78. 78 Small Molecules Efficiently Direct Endodermal Differentiation of Mouse and Human Embryonic Stem Cells [DOI]
  79. 79 Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence [DOI]
  80. 80 A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development [DOI]
  81. 81 Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex [DOI]
  82. 82 Myocardial tissue engineering: a review [DOI]
  83. 83 Good manufacturing practice and clinical-grade human embryonic stem cell lines [DOI]
  84. 84 Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors [DOI]
  85. 85 Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain [DOI]
  86. 86 Microfabrication of Three-Dimensional Engineered Scaffolds [DOI]
  87. 87 Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats [DOI]
  88. 88 Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis [DOI]
  89. 89 Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development [DOI]
  90. 90 A Common Progenitor at the Heart of Development [DOI]
  91. 91 Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex [DOI]
  92. 92 REVIEW ARTILCE: Cell therapy and stem cells in animal models of motor neuron disorders [DOI]
  93. 93 Inductive tissue engineering with protein and DNA-releasing scaffolds [DOI]
  94. 94 Cardiogenesis From Human Embryonic Stem Cells - Mechanisms and Applications - [DOI]
  95. 95 Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction [DOI]
  96. 96 Genome-Scale Mapping of MicroRNA Signatures in Human Embryonic Stem Cell Neurogenesis [DOI]
  97. 97 Important precautions when deriving patient-specific neural elements from pluripotent cells [DOI]
  98. 98 Human Stem Cell Derivatives Retain More Open Epigenomic Landscape When Derived from Pluripotent Cells than from Tissues [DOI]
  99. 99 Cortical development: the art of generating cell diversity [DOI]
  100. 100 Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors [DOI]
  101. 101 Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells [DOI]
  102. 102 Direct conversion of fibroblasts to functional neurons by defined factors [DOI]
  103. 103 Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro [DOI]
  104. 104 Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts [DOI]
  105. 105 Derivation of pluripotent epiblast stem cells from mammalian embryos [DOI]
  106. 106 Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease [DOI]
  107. 107 Directed Differentiation of Embryonic Stem Cells into Motor Neurons [DOI]
  108. 108 Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes [DOI]
  109. 109 Specification of motoneurons from human embryonic stem cells [DOI]
  110. 110 Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer [DOI]
  111. 111 Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice [DOI]
  112. 112 Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex [DOI]
  113. 113 Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages [DOI]
  114. 114 Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors [DOI]
  115. 115 A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration [DOI]
  116. 116 Dopaminergic Differentiation of Human Embryonic Stem Cells [DOI]
  117. 117 Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells [DOI]
  118. 118 Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts [DOI]
  119. 119 Nanostructured Scaffolds for Neural Applications [DOI]
  120. 120 Early Signals in Cardiac Development [DOI]
  121. 121 Cardiac Regeneration using Human Embryonic Stem Cells: Producing Cells for Future Therapy [DOI]
  122. 122 MicroRNA Profiling Reveals Distinct Mechanisms Governing Cardiac and Neural Lineage-Specification of Pluripotent Human Embryonic Stem Cells [DOI]
  123. 123 Patents on Technologies of Human Tissue and Organ Regeneration from Pluripotent Human Embryonic Stem Cells [DOI]
  124. 124 Human Trials for Neurodegenerative Disease [DOI]
  125. 125 Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage [DOI]

Cited by 9

Induction of sensory neurons from neuroepithelial stem cells by the ISX9 small molecule.

Ali RQ, Blomberg E, Falk A · Am J Stem Cells · 2016

Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons.

Bradford AB, McNutt PM. · World J Stem Cells · 2015

Showing 2 of 9 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

72

Page views

0

PDF downloads

37

Outbound clicks

9

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.